The ACME Laboratories Ltd. (DSE:ACMELAB)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
83.90
+1.30 (1.57%)
At close: Aug 31, 2025
1.57%
Market Cap17.48B
Revenue (ttm)34.75B
Net Income (ttm)2.40B
Shares Out211.60M
EPS (ttm)11.36
PE Ratio7.27
Forward PEn/a
Dividend3.50 (4.24%)
Ex-Dividend DateNov 21, 2024
Volume1,275,874
Average Volume474,826
Open82.70
Previous Close82.60
Day's Range82.70 - 84.80
52-Week Range67.90 - 94.50
Beta0.08
RSI60.09
Earnings DateOct 22, 2025

About The ACME Laboratories

The ACME Laboratories Ltd., a pharmaceutical company, engages in the manufacture, market, and distribution of generic pharmaceutical formulation products in Bangladesh. The company offers pharmaceutical products in various therapeutic areas, such as allergic disorders, analgesic, antifribinolytic, anti-infective, antiviral, artificial sweeteners, cardiovascular, central nervous system (CNS), cough and cold, diabetes, eye care and preparations, gastroprokinetic, hepatobiliary, gastrointestinal, gynaecological, hand sanitizers, hormones and stero... [Read more]

Industry Pharmaceutical Preparations
Founded 1954
Employees 9,301
Stock Exchange Dhaka Stock Exchange
Ticker Symbol ACMELAB
Full Company Profile

Financial Performance

In 2024, The ACME Laboratories's revenue was 31.93 billion, an increase of 18.49% compared to the previous year's 26.95 billion. Earnings were 2.46 billion, an increase of 6.62%.

Financial Statements

News

There is no news available yet.